Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status
Crossref DOI link: https://doi.org/10.1186/1710-1492-10-S2-A52
Published Online: 2014-12-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, WH
Casale, T
Bateman, ED
Dahl, R
Pizzichini, E
Vandewalker, M
Virchow, JC
Engel, M
Moroni-Zentgraf, PM
Schmidt, H
Kerstjens, HAM
Article History
First Online: 18 December 2014